Ameriprise
ANGO icon

Ameriprise’s AngioDynamics ANGO Stock Holding History

Ameriprise’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.18M Sell
104,140
-19,197
-16% -$208K ﹤0.01% 3220
2025
Q4 		$1.58M Sell
123,337
-4,150
-3% -$51.2K ﹤0.01% 3120
2025
Q3 		$1.42M Hold
127,487
– – ﹤0.01% 3188
2025
Q2 		$1.26M Sell
127,487
-150
-0.1% -$1.47K ﹤0.01% 3172
2025
Q1 		$1.2M Sell
127,637
-149,928
-54% -$1.58M ﹤0.01% 3132
2024
Q4 		$2.54M Buy
277,565
+53,675
+24% +$395K ﹤0.01% 2790
2024
Q3 		$1.74M Buy
223,890
+35,189
+19% +$254K ﹤0.01% 2981
2024
Q2 		$1.14M Sell
188,701
-17,130
-8% -$106K ﹤0.01% 3109
2024
Q1 		$1.21M Sell
205,831
-17,560
-8% -$104K ﹤0.01% 3094
2023
Q4 		$1.75M Buy
223,391
+48,712
+28% +$338K ﹤0.01% 2937
2023
Q3 		$1.28M Sell
174,679
-109,743
-39% -$913K ﹤0.01% 3034
2023
Q2 		$2.97M Sell
284,422
-6,688
-2% -$64.4K ﹤0.01% 2675
2023
Q1 		$3.01M Buy
291,110
+13,669
+5% +$175K ﹤0.01% 2640
2022
Q4 		$3.82M Sell
277,441
-10,447
-4% -$145K ﹤0.01% 2470
2022
Q3 		$5.89M Sell
287,888
-229,226
-44% -$5.03M ﹤0.01% 2091
2022
Q2 		$10M Sell
517,114
-9,420
-2% -$193K ﹤0.01% 1752
2022
Q1 		$11.3M Buy
526,534
+29,316
+6% +$665K ﹤0.01% 1815
2021
Q4 		$13.7M Buy
497,218
+206,211
+71% +$5.69M ﹤0.01% 1710
2021
Q3 		$7.55M Sell
291,007
-378
-0.1% -$10.1K ﹤0.01% 2084
2021
Q2 		$7.9M Sell
291,385
-45,393
-13% -$1.11M ﹤0.01% 2114
2021
Q1 		$7.88M Buy
336,778
+24,165
+8% +$488K ﹤0.01% 2065
2020
Q4 		$4.79M Sell
312,613
-11,833
-4% -$150K ﹤0.01% 2303
2020
Q3 		$3.91M Sell
324,446
-36,789
-10% -$349K ﹤0.01% 2257
2020
Q2 		$3.67M Sell
361,235
-161,645
-31% -$1.67M ﹤0.01% 2280
2020
Q1 		$5.45M Buy
522,880
+58,570
+13% +$735K ﹤0.01% 1852
2019
Q4 		$7.43M Buy
464,310
+171,052
+58% +$2.61M ﹤0.01% 1975
2019
Q3 		$5.4M Sell
293,258
-8,264
-3% -$162K ﹤0.01% 2162
2019
Q2 		$5.94M Sell
301,522
-53,208
-15% -$1.08M ﹤0.01% 2124
2019
Q1 		$8.11M Sell
354,730
-147,062
-29% -$3.19M ﹤0.01% 1882
2018
Q4 		$10.1M Sell
501,792
-85,684
-15% -$1.77M 0.01% 1597
2018
Q3 		$12.8M Sell
587,476
-219,446
-27% -$4.87M ﹤0.01% 1675
2018
Q2 		$17.9M Buy
806,922
+89,008
+12% +$1.82M 0.01% 1259
2018
Q1 		$12.4M Buy
717,914
+64,476
+10% +$1.08M 0.01% 1496
2017
Q4 		$10.9M Buy
653,438
+14,427
+2% +$246K 0.01% 1551
2017
Q3 		$10.9M Sell
639,011
-19,762
-3% -$332K 0.01% 1502
2017
Q2 		$10.7M Buy
658,773
+44,052
+7% +$696K 0.01% 1502
2017
Q1 		$10.7M Buy
614,721
+112,693
+22% +$1.88M 0.01% 1470
2016
Q4 		$8.47M Buy
502,028
+327,821
+188% +$5.47M ﹤0.01% 1649
2016
Q3 		$3.06M Buy
174,207
+14,655
+9% +$238K ﹤0.01% 2343
2016
Q2 		$2.29M Buy
159,552
+4,213
+3% +$52.6K ﹤0.01% 2456
2016
Q1 		$1.91M Buy
155,339
+34,878
+29% +$385K ﹤0.01% 2529
2015
Q4 		$1.46M Sell
120,461
-1,798
-1% -$22.1K ﹤0.01% 2769
2015
Q3 		$1.61M Buy
122,259
+1,544
+1% +$23.3K ﹤0.01% 2733
2015
Q2 		$1.98M Buy
120,715
+2,323
+2% +$38.6K ﹤0.01% 2766
2015
Q1 		$2.11M Buy
118,392
+5,432
+5% +$101K ﹤0.01% 2573
2014
Q4 		$2.15M Buy
+112,960
New +$1.91M ﹤0.01% 2536
2014
Q2 		– Sell
-60
Closed -$1K – 5582
2014
Q1 		$1K Hold
60
– – ﹤0.01% 5154
2013
Q4 		$1K Sell
60
-1,475
-96% -$22.7K ﹤0.01% 4969
2013
Q3 		$20K Sell
1,535
-461,648
-100% -$5.44M ﹤0.01% 4413
2013
Q2 		$5.23M Buy
+463,183
New +$4.93M ﹤0.01% 1863

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.5M AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
WCM
Weber Capital Management San Francisco, California $100M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAM
Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

Ameriprise's ANGO Position: Q1 2026 in Review

Ameriprise reduced its AngioDynamics (ANGO) stake by 16% in Q1 2026, selling an estimated $208K and leaving 104,140 shares worth $1.18M. The position accounts for ﹤0.01% of the portfolio, ranked #3220.

Ameriprise first reported a position in ANGO in Q2 2013 and has held it in 50 quarters since. The position peaked at $17.9M in Q2 2018. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • Ameriprise held 104,140 shares of AngioDynamics worth $1.18M as of Q1 2026.
  • Ameriprise sold 19,197 AngioDynamics shares in Q1 2026, an estimated $208K.
  • AngioDynamics made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #3220 holding.
  • Ameriprise first reported a position in AngioDynamics in Q2 2013 and has held it in 50 quarters since.
  • Ameriprise's AngioDynamics position peaked at $17.9M in Q2 2018.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.